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Abstract We sought a correlation between rat skeletal muscle
triiodothyronine (T3)-mediated regulation of uncoupling protein-
3 (UCP3) expression and mitochondrial activity. UCP3 mRNA
expression increased strongly during the hypothyroid-hyperthyr-
oid transition. The rank order of mitochondrial State 3 and State
4 respiration rates was hypothyroid6 euthyroid6 hyperthyroid.
The State 4 increase may have been due to the increased UCP3
expression, as the proton leak kinetic was stimulated in the
hypothyroid-hyperthyroid transition and a good correlation
exists between the State 4 and UCP3 mRNA level. As a
significant proportion of an organism’s resting oxygen consump-
tion is dedicated to opposing the proton leak, skeletal muscle
mitochondrial UCP3 may mediate part of T3’s effect on energy
metabolism.
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1. Introduction
Thyroid hormones (THs) play important roles in di¡eren-
tiation, growth, cognitive development and metabolism. In
adults, the most important e¡ect attributed to THs, in partic-
ular triiodothyronine (T3) and possibly diiodothyronine (T2),
is their in£uence on metabolic rate and the oxygen consump-
tion of nearly all tissues [1,2].
At the cellular level, T2 and T3 appear to have di¡erent
mechanisms of action.
T2 seems to act principally via mitochondria, while one of
the most important e¡ects attributed to T3 is the transcrip-
tional or post-transcriptional regulation of those target genes
encoding components of the mitochondrial energy-transduc-
ing apparatus (for reviews, see [3] and [4]). In this context,
e¡ects of particular interest are those exerted by T3 on the
regulation of the synthesis of uncoupling proteins (UCPs).
Apart from the well-known regulation of UCP1 by T3 [5], it
has recently been reported that T3 stimulates expression of the
mRNAs for both UCP2 (in several organs) [6,7] and UCP3
(in skeletal muscle) [8,9]. This is particularly interesting in
view of the old hypothesis that an uncoupling of respiration
and phosphorylation is involved in the e¡ects of thyroid hor-
mones. Although this idea has been under discussion for
many years, it is still not clear whether the reported uncou-
pling e¡ects of thyroid hormones re£ect physiological events,
or whether they are artifactual.
UCPs are di¡erently distributed and regulated in di¡erent
species, suggesting a variety of physiological roles.
1. UCP1 is present in very low amounts in adult humans,
and it is restricted to brown adipose tissue in newborns
as well as in small mammals, in whom it contributes to
the regulation of body temperature and to energy bal-
ance [10,11].
2. UCP2 is widely expressed in adult tissues in rodents and
humans, and it may play a role in the regulation of body
weight and energy balance, in fever and in the defence
against the generation of reactive oxygen species [12]
3. UCP3 is highly expressed in skeletal muscle in rodents
and humans where its expression is modulated by food
intake [13], thyroid hormones [8,9] and cold exposure
[14].
So far, a decrease in the mitochondrial electrochemical po-
tential due to UCP2 [15,16] or UCP3 [9,13] has been demon-
strated only in transformed yeast cells or in transfected C2C12
mouse myoblasts, and it would be important to show this
e¡ect in vivo. As thyroid hormones have a well-known fun-
damental role in the regulation of energy metabolism, and as
the contribution made by skeletal muscle to the rat’s meta-
bolic rate has been estimated to be about 30% [17], we
thought it interesting to measure the mitochondrial energy
coupling and the expression of UCP3 mRNA in skeletal
muscle from rats in di¡erent thyroid states. These experiments
for the ¢rst time could clearly demonstrate a correlation be-
tween the levels of UCP3 expression and mitochondria energy
coupling in one and the same animals. Since the maintenance
of a proton-motive force against the proton leak may account
for a signi¢cant proportion of the resting oxygen consumption
of an organism [18], we also examined the relationship be-
tween resting respiration rate v8 in oligomycin inhibited mi-
tochondria obtained from tissues underexpressing UCP3
mRNA (hypothyroid mitochondria) and those overexpressing
UCP3 mRNA (hyperthyroid mitochondria). Our results lead
us to hypothesize a possible role for mitochondrial skeletal
muscle UCP3 as one of the mediators of the e¡ect of T3 on
energy metabolism.
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2. Materials and methods
2.1. Rat treatment regimes and tissue sampling
Male Wistar rats (220^230 g) were kept, one per cage, under an
arti¢cial lighting regime of 12 h light:12 h darkness in a temperature-
controlled room at 28‡C. A commercial mash was available ad libitum
and the animals had free access to water. Hypothyroidism was pro-
duced in rats by a daily i.p. injection of 6-n-propylthiouracil (PTU)
(1 mg/100 g body weight) for 3 weeks, together with a weekly i.p.
injection of iopanoic acid (IOP) (6 mg/100 g body weight). Euthyroid
controls were sham-injected with saline.
Chronic hyperthyroidism was induced in euthyroid rats by seven
daily i.p. injections of 15 Wg T3/100 g body weight, while control rats
(euthyroid and hypothyroid) received saline injections. The iodothyr-
onine doses and the treatment duration were chosen so as to obtain a
change in the levels of the thyroid hormones without signi¢cantly
changing the body weight of the animals. At the end of the treatment
(24 h after the last dose of T3), rats were anaesthetized by i.p. admin-
istration of chloral hydrate (40 mg/100 g body weight) and killed by
decapitation. Skeletal muscles (hind-limb muscles) were isolated and
either immediately processed for the preparation of the mitochondria
or immediately frozen in liquid nitrogen, then stored at 380‡C until
further processing. All experiments were performed in accordance
with local and national guidelines covering animal experiments.
2.2. Mitochondrial preparations
Skeletal muscle fragments (1 g) were homogenized using a Potter
Evehjem homogenizer in 10 vol of an isolation medium consisting of
220 mM mannitol, 70 mM sucrose, 20 mM Tris-HCl, 1 mM EDTA,
5 mM EGTA and protease (1 mg/g tissue). In order not to damage the
mitochondria, the homogenization was carried out very gently and
5 min were allowed for the protease to act. In some experiments,
the isolation medium was supplemented with 0.5% (w/v) fatty acid-
free BSA. The homogenates were centrifuged at 500Ug for 10 min at
4‡C, the resulting supernatant was centrifuged at 8000Ug and the
pellet collected was washed twice in the same isolation medium. The
¢nal mitochondrial pellet was resuspended in a minimal volume and
kept on ice.
2.3. Measurement of membrane potential (v8) and respiration rate
v8 was determined from the distribution of the lipophilic cation
triphenylmethylphosphonium (Ph3MeP), which was measured using
a Ph3MeP-sensitive electrode, as described by Brown and Brand [19].
A Ph3MeP-binding correction of 0.4 was applied, as recommended
by Rolfe et al. [20]. v8 was measured in the presence of nigericine so
that the whole proton-motive force could be expressed as v8. Respi-
ration rate was determined simultaneously using a Clark-type oxygen
electrode.
Mitochondrial membrane potential and respiration rate were meas-
ured in a mitochondrial suspension (0.5 mg/ml) at 37‡C in standard
incubation medium (80 mM KCl, 50 mM HEPES (pH 7), 1 mM
EGTA, 5 mM K2HPO4, 4 WM rotenone, 80 ng/ml nigericine using
a saturating amount of succinate as substrate (5 mM). The State
4 and 3 of respiration were measured in the same incubation medium
without nigericine. State 3 respiration was initiated by addition of
ADP (300 WM) and RCR was calculated according to Estabrook
[21]. In some experiments, the incubation medium was supplemented
with 0.5% w/v fatty acid-free BSA.
The protein concentration was determined by the method of Har-
tree [22].
2.4. Determination of the kinetic response of the proton leak to changes
in membrane potential in skeletal muscle mitochondria
In resting mitochondria, the respiration rate has to account princi-
pally to the leak of protons across the inner membrane. For the
evaluation of the kinetic response of the mitochondrial proton leak
to a change in v8, the incubation medium was supplemented by
oligomycin (1 Wg/ml). The respiration rate was inhibited by sequential
addition of malonate (normally up to 2.5 mM, but up to 5 mM in
mitochondria obtained in presence of BSA). We chose an assay tem-
perature of 37‡C in order to be able to attribute the non-linear rela-
tionship between respiration rate and proton-motive force, obtained
when non-phosphorylating mitochondria are titrated with malonate,
to an increase in the proton leak conductance of the inner membrane
at high proton-motive force, instead of to a variation in the number of
protons pumped by the respiratory chain per oxygen atom consumed
[23,24].
2.5. RNA isolation and Northern blotting
Total RNAs from skeletal muscle were isolated by the method of
Chomczynski and Sacchi [25]. For Northern blots, 20 Wg of total
RNA was separated on a 1% (w/v) agarose/formaldehyde gel and
transferred onto nylon membranes with 20USSC (1USSC = 150
mM NaCl, 15 mM sodium citrate, pH 7.0). To detect speci¢c
mRNA, we used a 769 bp probe derived from rat UCP3 cDNA [26]
(GenBank accession number U92069) which was labelled with 32P
using a random priming system.
Hybridization and washing were carried out as described by Church
and Gilbert [27]. A 28S-derived oligonucleotide was used to normalize
the amount of RNA for each line.
3. Results
As shown in Fig. 1 (upper panel), the level of UCP3 mRNA
in the hind-limb muscle was much lower in hypothyroid rats
than in normal euthyroid animals, while in hyperthyroid rats
the UCP3 mRNA expression was strongly increased. The dif-
ferences were of the order of 5 times between euthyroid and
hypothyroid states and 5 times between hyperthyroid and eu-
thyroid states (lower panel).
As shown in Table 1, when respiring in the absence of BSA,
the mitochondria obtained from hyperthyroid rats had a res-
piratory rate in both State 3 and State 4 that was signi¢cantly
higher than the corresponding value for mitochondria from
hypothyroid animals. The percentage di¡erence between
States 4 and 3 was comparable for the three groups of rats
and the transition hypothyroid-euthyroid produced a greater
increase for State 4 and for State 3 than the transition euthy-
roid-hyperthyroid. The result of all this was that RCR (respi-
ratory control ratio) values were not signi¢cantly di¡erent
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Fig. 1. Upper panel: Expression levels of UCP3 mRNA in skeletal
muscle of hypothyroid, euthyroid and hyperthyroid rats. Lines:
N = euthyroid rats, T3 = hyperthyroid rats, H = hypothyroid rats.
Lower panel: UCP3 mRNA expression in hypothyroid and hyper-
thyroid skeletal muscle expressed as a percentage of the euthyroid
level (Molecular Image, Bio-Rad). Values shown are the mean þ
S.E.M. of three di¡erent determinations.
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among the three thyroid states. Similar results were obtained
when mitochondria were incubated in the presence of BSA,
except that State 4 respiration rates were lower and RCR
values were about 5 (data not shown).
Fig. 2 shows the kinetic response of the proton leak to a
change in v8 in skeletal muscle mitochondria from hypothy-
roid, euthyroid and hyperthyroid rats in the absence (upper
panel) or presence (lower panel) of fatty acid-free BSA. The
kinetic response of the proton leak to a change in v8 was
in£uenced by the thyroid state. A stimulation of the above
kinetics occurred in the hypothyroid-euthyroid-hyperthyroid
transition. In other words, at any given mitochondrial mem-
brane potential, respiration rate increased in the order hypo-
thyroid6 euthyroid6 hyperthyroid.
Since at an assay temperature of 37‡C there would be no
change in the e⁄ciency of the mitochondrial electron pump,
and assuming that the ratio H/O remains constant whatever
the thyroid states (as already shown in liver mitochondria
[28]), the di¡erence observed here between hypothyroid, eu-
thyroid and hyperthyroid mitochondria could be attributed to
a variation in the proton leak. As the present measurements
have been performed on skeletal muscle mitochondria, we
cannot exclude that an increase in conductance for ions other
than H and/or of a decrease in the H/e ratio of the respi-
ratory chain pumps could, at least in part, explain our results.
When the same analysis was performed on mitochondria pre-
pared in the presence of fatty acid-free BSA (Fig. 2 lower
panel) only a slight di¡erence in the kinetics of the proton
leak response was observed across the three thyroid states.
4. Discussion
The calorigenic e¡ect of thyroid hormones has been known
for many years and one of the oldest hypotheses put forward
to explain this e¡ect was that of Martius and Hess. These
authors obtained the ¢rst evidence that the in vitro addition
of thyroxine to mitochondria caused uncoupling, as measured
by a decrease in the RCR [28,29]. This hypothesis was sub-
sequently discarded because of the large doses required for the
e¡ect in vitro and the lack of similar observations in vivo.
Actually, mitochondria from animals in di¡erent thyroid
states do not show any di¡erence in RCR. This absence of
a change in RCR, however, does not exclude the possibility
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Fig. 2. Kinetic responses of proton leak to a change in v8 in skele-
tal muscle mitochondria: comparison between hypothyroid, euthy-
roid and hyperthyroid rats. Panels show the kinetics of the proton
leak in mitochondria prepared in the absence (upper panel) or pres-
ence (lower panel) of 0.5% BSA. The respiration medium was also
supplemented with 0.5% BSA. Each point represents the mean þ
S.E.M. of duplicate determinations in four di¡erent mitochondrial
preparations.
Fig. 3. Correlation analysis of UCP3 mRNA expression and State 4
respiration rate in di¡erent thyroid states. The relative values for
UCP3 mRNA expression and for State 4 respiration rate were each
obtained by dividing the value in a given thyroid state by the value
obtained for the hypothyroid state. The correlation parameters were
r = 0.999, r2 = 0.997; t = 18.26, P = 0.035.
Table 1
State 4 and State 3 respiration rates (nAtoms O/minUmg protein)
and RCR in skeletal muscle mitochondria from hypothyroid, euthy-
roid and hyperthyroid rats
Thyroid state
Hypothyroid Euthyroid Hyperthyroid
State 4 255 þ 4 311 þ 8* 351 þ 28*
State 3 507 þ 23 674 þ 44* 695 þ 34*
RCR 1.99 2.17 1.98
Values are the mean þ S.E. of four di¡erent mitochondrial prepara-
tions. Di¡erences were considered signi¢cant at P6 0.05 (Student-
Newman-Keuls test).
*P6 0.05 vs. hypothyroid state.
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that changes in State 3 and/or State 4 may occur. In fact, an
increase in both proton leak and phosphorylating machinery
(ATP synthase, adenine nucleotide translocator, phosphate
transporter) kinetics can lead to an unchanged set-point for
the coupling ratio [30]. Quite recently, it has been shown that
in cells from hyperthyroid animals the increased respiration is
caused by alterations in both the proton leak and phospho-
rylating system [30,31] without signi¢cant alterations in RCR.
The data presented in this report are in line with these obser-
vations. In the transition from a hypothyroid to a hyperthy-
roid state, we did not observe any change in RCR although
the values for State 4 increased signi¢cantly in the transition
from hypothyroid to euthyroid and from euthyroid to hyper-
thyroid state. The progressive increase of UCP3 expression in
the hypothyroid-euthyroid-hyperthyroid transition might be
the cause of the increase in State 4 respiration with which a
good correlation is observed (see Fig. 3).
As previously shown, UCP2 expression also shows an in-
crease in skeletal muscle in the transition hypothyroid-hyper-
thyroid [7]. However, the changes in UCP3 expression re-
ported here are of the order of 5 times, whereas the change
in UCP2 expression was by only about 60% [6,7]. It should be
pointed out that the changes in the State 4 respiration rate
and in the kinetic response of proton leak to v8 were not of
the same order of magnitude as those in UCP3 mRNA ex-
pression. The greatest changes in mitochondrial respiration
rate and in the kinetic response of proton leak to a change
in v8 were observed in the hypothyroid-euthyroid transition.
This shows that changes in mitochondrial respiration rate can
be observed in a range of physiological thyroid hormone val-
ues.
Taken together, the results of this study, showing a corre-
lation between UCP3 mRNA expression and mitochondrial
energy coupling, may explain the di¡erences observed among
muscle samples from animals in di¡erent thyroid states. Sim-
ilar changes in mitochondrial respiration rates have been ob-
served by Bobyleva et al. [32] in isolated rat hepatocytes and
by Hafner et al. [33] in rat liver mitochondria. Even if UCPs
are absent from hepatocytes (UCP2 is present only in Kup¡er
cells in the liver) suggesting that in this case another mecha-
nism has to be considered (the ATP/ADP antiporter could
mediate the mitochondrial proton conductance [32]), the
above changes in mitochondrial functions may represent a
typical cellular response, involving most tissues, to the thyroid
status of the animal.
The result of this study showing that no clear cut change in
proton leak kinetics is seen across the three thyroid states
when fatty acid-free BSA is present in the medium indicates
that free fatty acids may play a role in the observed e¡ects of
thyroid hormones supporting the hypothesis that UCP3 oper-
ates as carrier for fatty acid anions [34]. This is in agreement
with the results of Gonzales-Barroso et al. [35] who showed
that fatty acid may stimulate UCP or a non-speci¢c carrier
depending on the concentration of free fatty acids. In addition
it has already been shown that at least for UCP1 function free
fatty acids are requested [36].
Since it has been shown that (i) the ATP/ADP antiporter,
like UCP, also mediates the uncoupling e¡ects of fatty acids
[37] and (ii) there is a positive correlation between the thyroid
state and the ATP/ADP antiporter level [38], an involvement
of the ATP/ADP antiporter, in the observed mitochondrial
uncoupling, cannot be excluded.
It has been shown that thyroid hormones may also in£u-
ence the amount and the activity of the respiratory chain
components. However, these e¡ects seem not to be related
to changes in energy coupling.
In conclusion, the present results seem to support the idea
that uncoupling proteins (where present) may mediate the
e¡ects that thyroid hormones (in particular T3) exert at the
mitochondrial level and their general e¡ects on energy metab-
olism.
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